Back to search

France· FR:67563415

BURINEX 5 mg, comprimé

A bumetanide product containing bumétanide, registered in France by KARO PHARMA (SUEDE), on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC C03CA02

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedBURINEX 5 mg, compriméATCC03CA02REGISTER NO.FR:67563415PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Bumetanide is registered in 10 of 19 countries.

Countries holding a registration under ATC C03CA02 (bumetanide), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 5 of them publish a price we can compare per daily dose

Bumetanide · ATC C03CA02

10 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Ireland
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bumetanide costs, country by country.

Normalised to the WHO defined daily dose (1 mg), so markets compare like for like.

  • France: $0.13 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Bumetanide · price per daily dose (1 mg)

USD · FX 28 Sept 2026

  • FR France$0.13
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
BUMÉTANIDE
Manufacturer
KARO PHARMA (SUEDE)
Country
France (FR)
ATC code
C03CA02
ATC class
Bumetanide
Defined daily dose
1 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400934521393
    film(s) thermosoudé(s) aluminium de 30 comprimé(s)
    EUR 15.15

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

318 interactions on record for bumetanide.

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Bumetanide · interactions on record

318 records

  • 15 severe
  • 177 moderate
  • 9 minor
  • 116 info

Most severe, free to view

  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bumetanide in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bumetanide products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Burinex
  • Belgium · Burinex
  • Denmark · Burinex
  • Spain · Fordiuran
  • United Kingdom (Northern Ireland) · Bumetanide Generics Uk, Bumetanide Niche Generics
  • Greece · Burinex
  • Ireland · Burinex
  • Luxembourg · Burinex
  • Malta · Burinex
  • Netherlands · Bumetanide Cf, Bumetanide Sandoz
  • Norway · Burinex
  • Sweden · Burinex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f4258f6d-c3db-43c3-b88d-4a6505a3679e
GET /v1/drugs/f4258f6d-c3db-43c3-b88d-4a6505a3679e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "67563415",
  "date_amm": "1989-09-28",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "BUMÉTANIDE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about bumetanide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.